Category: Rx Cancer (A – Z)

What Is Plasma Cell Myeloma?/Plasma Cell Myeloma is a neoplastic plasma cell disorder that usually presents after the fifth decade of life; it is...

Plasma Cell Myeloma is a neoplastic plasma cell disorder that usually presents after the fifth decade of life; it is rarely described in the...

Plasmablastic Lymphoma (PBL) is an uncommon but aggressive subtype of diffuse, large, B-cell lymphoma. The diagnosis of PBL is difficult because its features overlap...

Multiple Myeloma (MM) is a fatal, malignant B-cell neoplasm characterized by uncontrolled, destructive growth of mutated plasma cells within the bone marrow (BM). Patients...

MGUS (Monoclonal Gammopathy of Undetermined Significance) is characterized by a serum M protein concentration of less than 30 g/L, fewer than 10% clonal plasma...

Monoclonal Gammopathy of Undetermined Significance (MGUS) is characterized by a serum M protein concentration of less than 30 g/L, fewer than 10% clonal plasma...

Lymphoplasmacytic Lymphoma (LPL) is a rare type of non-Hodgkin lymphoma that is characterized by infiltration of small B lymphocytes, plasmacytoid lymphocytes, and plasma cells....

Follicular Lymphoma (FL) is the second most common type of non-Hodgkin lymphoma (NHL) and accounts for almost 30% of all lymphomas. It is number...

Hairy Cell Leukemia (HCL) is a relatively rare chronic B-cell malignancy that involves the bone marrow, spleen, and peripheral blood. The complete blood count...

Splenic Marginal Zone Lymphoma (also known as splenic marginal zone B-cell lymphoma) is one of a family of indolent B-cell lymphomas that remain incompletely...

B-cell Prolymphocytic Leukemia (B-PLL) is a rare, aggressive leukemia distinct from chronic lymphocytic leukemia. B-PLL is resistant to most chemotherapy and newer targeted therapies...

Lymphoproliferative Disorders (LPD) comprise a heterogeneous group of diseases characterized by uncontrolled production of lymphocytes that cause monoclonal lymphocytosis, lymphadenopathy and bone marrow infiltration....

Monoclonal B Lymphocytosis (MBL) is defined as the presence of a clonal B-cell population in the peripheral blood with fewer than 5 × 109/L...

Lymphoma are a heterogeneous group of malignancies that arise from the clonal proliferation of B- cell, T- cell and natural killer (NK) cell subsets of lymphocytes at different...

Non-Hodgkin lymphoma (NHL) is a neoplasm of the lymphoid tissues, which originates from B cell precursors, mature B cells, T cell precursors, and mature T cells. Non-Hodgkin...

Chronic Lymphocytic Leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Chronic...

Chronic Myelogenous Leukemia BCR–ABL1+ (CML) is a myeloproliferative neoplasm that originates in a pluripotent bone marrow stem cell and is consistently associated with the BCR–ABL1...

Chronic Myeloid Leukemia (CML) is a cancer of blood cells, characterized by replacement of the bone marrow with malignant, leukemic cells. Many of these...

Acute Myelosclerosis/Acute Panmyelosis with Myelofibrosis (APMF) is a rare form of acute myeloid leukemia and is characterized by acute panmyeloid proliferation with increased blasts...

Acute (Malignant) Myelosclerosis/Acute Panmyelosis with Myelofibrosis (APMF) is a rare form of acute myeloid leukemia and is characterized by acute panmyeloid proliferation with increased...